Category: quinoxaline

62163-09-1, 5-Chloroquinoxaline is a quinoxaline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated,62163-09-1

EXAMPLE IV 5-(1-piperazinyl)quinoxalin, hydrochloride. 0.2 Mol (33.5 g) of 5-chloroquinoxalin and 2.1 mol (184 g) of piperazine were mixed in 180 ml of ethylene glycol and refluxed for 20 hours. The reaction mixture was poured on ice and acidified with concentrated hydrochloric acid and then extracted with 3*200 ml of ether. The water layer was made alkaline while cooling with ice, with 50% sodium hydroxide and then extracted with 3*600 ml of methylene chloride. The combined methylene chloride solution was washed successively with 1 l of 1N sodium hydroxide and a mixture of 925 ml of a saturated saline solution and 75 ml of 50% potassium hydroxide. The organic solution was dried on sodium sulphate and was then evaporated to dryness in vacuo. The residue was chromatographed over silica gel with a mixture of methylene chloride, methanol, and 25% ammonia (92:7.5:0.5) as eluent. The resulting free base was dissolved in ethanol and 1 equivalent of hydrochloric acid in ethanol was added. The title compound was obtained with a melting-point of 271-272 C.

The synthetic route of 62163-09-1 has been constantly updated, and we look forward to future research findings.

Reference：
Patent; Duphar International Research B.V.; US5424313; (1995); A;,
Quinoxaline – Wikipedia
Quinoxaline | C8H6N2 | ChemSpider

62163-09-1, 5-Chloroquinoxaline is a quinoxaline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated,62163-09-1

EXAMPLE IV 5-(1-piperazinyl)quinoxalin, hydrochloride. 0.2 Mol (33.5 g) of 5-chloroquinoxalin and 2.1 mol (184 g) of piperazine were mixed in 180 ml of ethylene glycol and refluxed for 20 hours. The reaction mixture was poured on ice and acidified with concentrated hydrochloric acid and then extracted with 3*200 ml of ether. The water layer was made alkaline while cooling with ice, with 50% sodium hydroxide and then extracted with 3*600 ml of methylene chloride. The combined methylene chloride solution was washed successively with 1 l of 1N sodium hydroxide and a mixture of 925 ml of a saturated saline solution and 75 ml of 50% potassium hydroxide. The organic solution was dried on sodium sulphate and was then evaporated to dryness in vacuo. The residue was chromatographed over silica gel with a mixture of methylene chloride, methanol, and 25% ammonia (92:7.5:0.5) as eluent. The resulting free base was dissolved in ethanol and 1 equivalent of hydrochloric acid in ethanol was added. The title compound was obtained with a melting-point of 271-272 C.

The synthetic route of 62163-09-1 has been constantly updated, and we look forward to future research findings.

Reference：
Patent; Duphar International Research B.V.; US5424313; (1995); A;,
Quinoxaline – Wikipedia
Quinoxaline | C8H6N2 | ChemSpider

91895-29-3, 6,7-Difluoroquinoxaline-2,3(1H,4H)-dione is a quinoxaline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

Example 88 Preparation of 6,7-Difluoro-5-nitro-1,4-dihydro-2,3-quinoxalinedione To a suspension of 6,7-difluoro-1,4-dihydro-2,3-quinoxalinedione (837 mg, 4.23 mmol) in trifluoracetic acid (30 mL) was added KNO3 (512 mg, 5.07 mmol). The mixture was stirred at 55 C. for 20 h at the end of this time, 256 mg (2.50 mmol) of KNO3 was added and the reaction mixture was stirred at 55 C. for 20 h, then another 256 mg (2.50 mmol) of KNO3 was added and the mixture was stirred at 55 C. for 20 h. The reaction mixture was then rota-evaporated to dryness. To the residual solid was added ice-cold water (about 15 mL), the solid was collected by vacuum filtration, washed with ice-cold water (5*5 mL), and dried at 40 C. under 1 mm Hg for 14 h, giving 700 mg (68%) of the title compound as a yellow powder. Mp 288-90 C. (dec.). IR (KBr) 3424, 3226, 1752, 1717, 1554, 1356, 1304 cm-1. 1 H NMR (DMSO-d6): 12.249 (s, 1H), 11.864 (bs, 1H), 7.330 (dd, 1H, J=10.5, 7.8 Hz). Analysis for C8 H3 F2 N3 O4, calcd: C, 39.50, H, 1.24, N, 17.29; found: C, 39.42, H, 1.26, N, 17.08., 91895-29-3

91895-29-3 6,7-Difluoroquinoxaline-2,3(1H,4H)-dione 822839, aquinoxaline compound, is more and more widely used in various fields.

Reference：
Patent; The State of Oregon, acting by and through The Oregon State Board of Higher Education, acting for and on behalf of The Oregon Health Sciences University; The University of Oregon; The Regents of the University of California; US5514680; (1996); A;,
Quinoxaline – Wikipedia
Quinoxaline | C8H6N2 | ChemSpider

62163-09-1, 5-Chloroquinoxaline is a quinoxaline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated,62163-09-1

EXAMPLE IV 5-(1-piperazinyl)quinoxalin, hydrochloride. 0.2 Mol (33.5 g) of 5-chloroquinoxalin and 2.1 mol (184 g) of piperazine were mixed in 180 ml of ethylene glycol and refluxed for 20 hours. The reaction mixture was poured on ice and acidified with concentrated hydrochloric acid and then extracted with 3*200 ml of ether. The water layer was made alkaline while cooling with ice, with 50% sodium hydroxide and then extracted with 3*600 ml of methylene chloride. The combined methylene chloride solution was washed successively with 1 l of 1N sodium hydroxide and a mixture of 925 ml of a saturated saline solution and 75 ml of 50% potassium hydroxide. The organic solution was dried on sodium sulphate and was then evaporated to dryness in vacuo. The residue was chromatographed over silica gel with a mixture of methylene chloride, methanol, and 25% ammonia (92:7.5:0.5) as eluent. The resulting free base was dissolved in ethanol and 1 equivalent of hydrochloric acid in ethanol was added. The title compound was obtained with a melting-point of 271-272 C.

The synthetic route of 62163-09-1 has been constantly updated, and we look forward to future research findings.

Reference：
Patent; Duphar International Research B.V.; US5424313; (1995); A;,
Quinoxaline – Wikipedia
Quinoxaline | C8H6N2 | ChemSpider

91895-29-3, 6,7-Difluoroquinoxaline-2,3(1H,4H)-dione is a quinoxaline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

Example 88 Preparation of 6,7-Difluoro-5-nitro-1,4-dihydro-2,3-quinoxalinedione To a suspension of 6,7-difluoro-1,4-dihydro-2,3-quinoxalinedione (837 mg, 4.23 mmol) in trifluoracetic acid (30 mL) was added KNO3 (512 mg, 5.07 mmol). The mixture was stirred at 55 C. for 20 h at the end of this time, 256 mg (2.50 mmol) of KNO3 was added and the reaction mixture was stirred at 55 C. for 20 h, then another 256 mg (2.50 mmol) of KNO3 was added and the mixture was stirred at 55 C. for 20 h. The reaction mixture was then rota-evaporated to dryness. To the residual solid was added ice-cold water (about 15 mL), the solid was collected by vacuum filtration, washed with ice-cold water (5*5 mL), and dried at 40 C. under 1 mm Hg for 14 h, giving 700 mg (68%) of the title compound as a yellow powder. Mp 288-90 C. (dec.). IR (KBr) 3424, 3226, 1752, 1717, 1554, 1356, 1304 cm-1. 1 H NMR (DMSO-d6): 12.249 (s, 1H), 11.864 (bs, 1H), 7.330 (dd, 1H, J=10.5, 7.8 Hz). Analysis for C8 H3 F2 N3 O4, calcd: C, 39.50, H, 1.24, N, 17.29; found: C, 39.42, H, 1.26, N, 17.08., 91895-29-3

91895-29-3 6,7-Difluoroquinoxaline-2,3(1H,4H)-dione 822839, aquinoxaline compound, is more and more widely used in various fields.

Reference：
Patent; The State of Oregon, acting by and through The Oregon State Board of Higher Education, acting for and on behalf of The Oregon Health Sciences University; The University of Oregon; The Regents of the University of California; US5514680; (1996); A;,
Quinoxaline – Wikipedia
Quinoxaline | C8H6N2 | ChemSpider

Application of 148231-12-3, New Advances in Chemical Research in 2021. The transformation of simple hydrocarbons into more complex and valuable products via catalytic C–H bond functionalisation has revolutionised modern synthetic chemistry. 148231-12-3, Name is 5,8-Dibromoquinoxaline, molecular formula is C8H4Br2N2. In a article，once mentioned of 148231-12-3

Dehalogenation polycondensation of 5,8-dibromoquinoxaline derivatives and 2,6-dibromoquinoxaline with zerovalent nickel complex affords a series of pi-conjugated polyquinoxalines with a molecular weight of 6 x 103 to 260 x 103. The polymers are electrochemically reduced (or n-doped) with an E value of -1.75 to -2.35 V vs Ag/Ag+ and converted into electrically conducting materials with a conductivity of 1 x 10-4 to 7 x 10-3 S cm-1 by chemical reduction. Poly(quinoxaline-5,8-diyl)s with aromatic substituents give strong fluorescence with emission peaks at 450-520 nm in solutions as well as in cast films. A light-emitting diode (LED), ITO/polymer/Mg(Ag) (polymer = poly(2,3-diphenylquinoxaline-5,8-diyl)), emits blue-green light (lambda(max) at about 500 nm). Introduction of hole-transporting layers such as vacuum-deposited or spin-coated thin layers of poly(thiophene-2,5-diyl), poly(p-phenylene), and poly(N-vinylcarbazole) between ITO and the light-emitting layer enhances electroluminescence efficiency by about 2 orders of magnitude. Polyquinoxalines have an ionization potential of 5.83 ± 0.11 eV and a band gap of 2.56 ± 0.26 eV.

We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 148231-12-3, and how the biochemistry of the body works.Application of 148231-12-3

Reference：
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2052 | ChemSpider

New Advances in Chemical Research, May 2021. In heterogeneous catalysis, catalysts provide a surface to which reactants bind in a process of adsorption. 1910-90-3, In a article, mentioned the application of 1910-90-3, Name is 6-Bromoquinoxaline-2,3(1H,4H)-dione, molecular formula is C8H5BrN2O2

An efficient one-pot reaction has been developed for the synthesis of 2,3-dichloroquinoxaline derivatives 3a?n. The reaction was performed in two steps via a silica gel catalyzed tandem process from o-phenylenediamine and oxalic acid, followed by addition of phosphorus oxychloride (POCl3). A variety of 2,3-dichloroquinoxalines have been obtained in good to excellent overall yields. Eight known compounds 3a?3h were characterized by IR, 1H-NMR, and mass spectroscopies. Compounds 3i?3n without spectroscopic data were characterized by IR, 1H-NMR, 13C-NMR, and mass spectroscopies.

The proportionality constant is the rate constant for the particular unimolecular reaction. the reaction rate is directly proportional to the concentration of the reactant. I hope my blog about 1910-90-3 is helpful to your research. 1910-90-3

Reference：
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1945 | ChemSpider

Electric Literature of 2213-63-0, New research progress on 2213-63-0 in 2021. As an important bridge between the micro and macro material world, chemistry is one of the main methods and means for humans to understand and transform the material world.2213-63-0, Name is 2,3-Dichloroquinoxaline, molecular formula is C8H4Cl2N2. In a article，once mentioned of 2213-63-0

The invention features quinoxalinones, pharmaceutical compositions containing them and methods of using them to treat, for example, diabetes.

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Electric Literature of 2213-63-0. In my other articles, you can also check out more blogs about 2213-63-0

Reference：
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1135 | ChemSpider

Reference of 59564-59-9, New Advances in Chemical Research in 2021. Because a catalyst decreases the height of the energy barrier, its presence increases the reaction rates of both the forward and the reverse reactions by the same amount.59564-59-9, Name is 3,4-Dihydroquinoxalin-2(1H)-one, molecular formula is C8H8N2O. In a article，once mentioned of 59564-59-9

Several dichloroacetamides of 1,5-benzodiazepinones and of tetrahydroquinoxalinones have been synthesised and screened for luminal antiamoebic activity.Only compound 1 exhibit notable activity in this series against luminal amoebiasis.

We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 59564-59-9, and how the biochemistry of the body works.Reference of 59564-59-9

Reference：
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N169 | ChemSpider

Application In Synthesis of 6-Bromo-2-chloro-3-methylquinoxaline, New research progress on 98416-72-9 in 2021. As an important bridge between the micro and macro material world, chemistry is one of the main methods and means for humans to understand and transform the material world.98416-72-9, Name is 6-Bromo-2-chloro-3-methylquinoxaline, molecular formula is C9H6BrClN2. In a article，once mentioned of 98416-72-9

In an effort to develop potent anti-cancer agents, we have synthesized some substituted quinoxaline derivatives. Reaction of 6-bromo-3-methylquinoxalin-2(1H)-one 1 with aromatic aldehydes furnished the styryl derivatives 2a-e. Alkylation of 1 with ethyl chloroacetate produced the N-alkyl derivatives 3. Hydrazinolysis of the ester derivative 3 with hydrazine hydrate afforded the hydrazide derivative 4. In addition, chlorination of 1 with phosphorus oxychloride afforded the 2-chloro derivative 5 which was used as a key intermediate for the synthesis of substituted quinoxaline derivatives 6-8, N-pyrazole derivative 9, tetrazolo[1,5-a]quinoxaline derivative 10 and Schiff base derivatives 13, 15 via reaction with several nucleophiles reagents. Docking methodologies were used to predict their binding conformation to explain the differences of their tested biological activities. All the tested compounds were screened in vitro for their cytotoxic effect on three tumor cell lines. Some new quinoxaline derivatives were studied as inhibitors of c-Met kinase, a receptor associated with high tumor grade and poor prognosis in a number of human cancers. Compounds 2e, 4, 7a, 12a, 12b and 13 showed the highest binding affinity with CDOCKER energy score, while showed the lowest IC50 values against three types of cancer cell lines. It is worth to mention that, compounds 2e, 7a, 12b and 13 showed comparable inhibition activity to the reference drug, while compounds 4 and 12a showed a more potent inhibition activity than Doxorubicin.

We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 98416-72-9, and how the biochemistry of the body works.Application In Synthesis of 6-Bromo-2-chloro-3-methylquinoxaline

Reference：
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1991 | ChemSpider